CompletedNot Applicable

Cannabis Impairment Detection Device Study

Canada362 participantsStarted 2022-09-08

Plain-language summary

The goal of this study is to develop a cannabis impairment detection device in adult cannabis users. The main question\[s\] it aims to answer are: * Is the investigational device accurate and reliable at detecting cannabis impairment? * is the device safe for the collection of eye movement data from cannabis intoxicated individuals? Participants will be administered a series of Drug Recognition Expert Ocular Tests via the Gaize headset following cannabis consumption.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults 19, years or older, having given written informed consent to participate in the research trial and certifying that they will not drive for a period of at least 6 hours post discharge. * Having used cannabis at least one time prior * Having access to legal cannabis * Normal or corrected to normal vision using either glasses or contact lenses, or surgery. Exclusion Criteria: * Enrolled in, or participated in another clinical trial within 30 days before the study * Having a prosthetic eye * Blood pressure greater than 160/90 mmHg and heart rate greater than 100 bpm.

What they're measuring

Incidence of device/procedure related Adverse Events/Serious Adverse Events during study intervention

Timeframe: Immediately after testing.

Trial details

NCT IDNCT07122349

SponsorGaize

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-10-24

View on ClinicalTrials.gov More Cannabis Intoxication trials